Loading…

Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection

Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection Diego Romero-Perez, Eduardo Fricovsky, Katrina Go Yamasaki, Michael Griffin, Maraliz Barraza-Hidalgo, Wolfgang Dillmann, Francisco Villarreal Tetracyclines are being examined for their potential to prevent and/or limit the pro...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2008-09, Vol.52 (13), p.1086-1094
Main Authors: Romero-Perez, Diego, BS, Fricovsky, Eduardo, PharmD, Yamasaki, Katrina Go, BS, Griffin, Michael, PhD, Barraza-Hidalgo, Maraliz, BS, Dillmann, Wolfgang, MD, Villarreal, Francisco, MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection Diego Romero-Perez, Eduardo Fricovsky, Katrina Go Yamasaki, Michael Griffin, Maraliz Barraza-Hidalgo, Wolfgang Dillmann, Francisco Villarreal Tetracyclines are being examined for their potential to prevent and/or limit the progression of many diseases. Here, we demonstrate that minocycline significantly reduces infarct size in rats subjected to ischemia-reperfusion injury. A substantial accumulation of the drug in normal and ischemic tissues was observed. The accumulation followed the capacity of cardiac cells to uptake the compound. Infarcted myocardium demonstrated reduced levels of matrix metalloproteinase-9 activity and tissue oxidative stress in animals treated with minocycline. On the basis of the millimolar concentrations observed inside the cells, it is likely that tetracyclines yield tissue protection via mass action effects.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2008.06.028